All people

Dr. Jon Salmanton-García

Cologne/ DE

University Hospital Cologne

Speaker

    • Poster
    • P-1-53
    Country-specific needs, ethics and regulatory requisites related to implementing a trial volunteer registry across Europe: the vaccelerate volunteer registry experience
     Immune Prevention and Therapy
    • Poster
    • P-1-51
    Establishing the vaccelerate site network: capacity mapping of clinical trial sites
     Immune Prevention and Therapy
    • Poster
    • P-1-42
    Improved clinical outcome of Covid-19 in haematologic malignancy patients receiving a fourth dose of anti-SARS-Cov-2 vaccine: an epicovideha report
     Immune Prevention and Therapy
    • Poster
    • P-1-55
    Laboratory capacities to diagnose and treat invasive fungal infections in Austria, Germany and Switzerland
     Immune Prevention and Therapy
    • Poster
    • P-1-47
    Laboratory capacities to diagnose and treat invasive fungal infections in Europe: results from the ECMM survey
     Immune Prevention and Therapy
    • Poster
    • P-1-56
    Laboratory capacities to diagnose and treat invasive fungal infections in Italy: local results from an ECMM survey
     Immune Prevention and Therapy
    • Poster
    • P-1-57
    Laboratory capacities to diagnose and treat invasive fungal infections in Nordic countries: results from an NSMM and ECMM survey
     Immune Prevention and Therapy
    • Poster
    • P-1-43
    Molnupiravir compared to nirmatrelvir/ritonavir for Covid-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the epicovideha registry
     Immune Prevention and Therapy
    • Poster
    • P-1-49
    Multipathogen antigen test kit (MAK-5) - distribution and frequency of viral respiratory diseases in Germany among volunteers in the vaccelerate registry
     Immune Prevention and Therapy
    • Poster
    • P-1-44
    Nirmatrelvir/ritonavir in Covid-19 patients with haematological malignancies: a report from the epicovideha registry
     Immune Prevention and Therapy
    • Poster
    • P-1-50
    Poliovirus vaccination status among adult participants in the vaccelerate volunteer registry
     Immune Prevention and Therapy
    • Poster
    • P-1-45
    Pre-exposure immunization by tixagevimab/cilgavimab in hematological malignancy and Covid-19 in the epicovideha registry
     Immune Prevention and Therapy
    • Poster
    • P-1-46
    The current state of laboratory mycology in Asia/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
     Immune Prevention and Therapy
    • Poster
    • P-1-52
    The first two years of the European vaccelerate volunteer registry
     Immune Prevention and Therapy
    • Poster
    • P-2-2
    Research nurses in Europe: education paths and key tasks. Results from VACCELERATE
     Data Science and Bioresources
    • Poster
    • P-2-1
    Public health communication for vaccine trials: the VACCELERATE pan-European toolkit
     Susceptibility to Infectious Diseases: Challenges and Ways Towards New Solutions
  • –   
    • Highlight-Vortrag
    • S-6-2
    Multipathogen Antigen Test Kit (MAK-5) – distribution and frequency of viral respiratory diseases in Germany among volunteers in the VACCELERATE Registry
     Tropical and Emerging Infections

Further involvements

    • v1.19.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy